Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms linking the human gut microbiome to prophylactic and treatment strategies for COVID-19
Gemma E. Walton, Glenn R. Gibson, Kirsty Hunter
British Journal Of Nutrition (2020) Vol. 126, Iss. 2, pp. 219-227
Open Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021?
Viktoria Hawryłkowicz, Danuta Lietz‐Kijak, Karolina Kaźmierczak-Siedlecka, et al.
Nutrients (2021) Vol. 13, Iss. 10, pp. 3385-3385
Open Access | Times Cited: 23
An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19
Kobra Ziyaei, Zahra Ataie, Majid Mokhtari, et al.
International Journal of Biological Macromolecules (2022) Vol. 209, pp. 244-257
Open Access | Times Cited: 16
Is butyrate a natural alternative to dexamethasone in the management of CoVID-19?
Nithin Kuriakose, Prakash Patil, Satheesh Kumar Bhandary, et al.
F1000Research (2021) Vol. 10, pp. 273-273
Open Access | Times Cited: 22
Novel Insights into the Role of Probiotics in Respiratory Infections, Allergies, Cancer, and Neurological Abnormalities
Igori Balta, Eugenia Butucel, Valentyn Mohylyuk, et al.
Diseases (2021) Vol. 9, Iss. 3, pp. 60-60
Open Access | Times Cited: 21
Antioxidant/anti‐inflammatory effect of Mg 2+ in coronavirus disease 2019 (COVID‐19)
Yalith Lyzet Arancibia‐Hernández, Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 15
Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?
Sandrayee Brahma, Amruta Naik, Ronan Lordan
Clinical Nutrition ESPEN (2022) Vol. 51, pp. 17-27
Open Access | Times Cited: 15
Clinical features and mechanistic insights into drug repurposing for combating COVID-19
Purva Asrani, Keshav Tiwari, Mathew Suji Eapen, et al.
The International Journal of Biochemistry & Cell Biology (2021) Vol. 142, pp. 106114-106114
Open Access | Times Cited: 16
Probiotics for the Prevention of Acute Respiratory-Tract Infections in Older People: Systematic Review
Maja Strauss, Dušanka Mičetić‐Turk, Maja Šikić Pogačar, et al.
Healthcare (2021) Vol. 9, Iss. 6, pp. 690-690
Open Access | Times Cited: 14
Exploring the binding capacity of lactic acid bacteria derived bacteriocins against RBD of SARS-CoV-2 Omicron variant by molecular simulations
İsmail Erol, Seyfullah Kotil, Fatih Ortakcı, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 20, pp. 10774-10784
Closed Access | Times Cited: 5
Prolonged viral shedding in feces of children with COVID-19: a systematic review and synthesis of data
Wenting Li, Yun Zhang, Miao Liu, et al.
European Journal of Pediatrics (2022) Vol. 181, Iss. 12, pp. 4011-4017
Open Access | Times Cited: 9
The Role of Gut Microbiota Dysbiosis as a Potential Factor in Early Diagnosis, Prognosis and Therapeutic Strategy of COVID-19 Patients
Kevin Tandarto, Kadek Ari Suyandi, Lily Chandrawati
The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy (2024) Vol. 24, Iss. 3, pp. 242-242
Open Access | Times Cited: 1
The Role of Gut Microbiota Dysbiosis as a Potential Factor in Early Diagnosis, Prognosis and Therapeutic Strategy of COVID-19 Patients
Kevin Tandarto, Kadek Ari Suyandi, Lily Chandrawati
The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy (2024) Vol. 24, Iss. 3, pp. 242-242
Open Access | Times Cited: 1
Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study
Lennard P. L. Gilissen, Stefan G. H. Heinen, Lotte Rijpma-Jacobs, et al.
Clinical and Experimental Medicine (2021) Vol. 22, Iss. 3, pp. 465-476
Open Access | Times Cited: 12
COVID-19 and the Human Gut Microbiome: An Under-Recognized Association
Abu Fahad Abbasi, Aleksandra Marinkovic, Stephanie Prakash, et al.
Chonnam Medical Journal (2022) Vol. 58, Iss. 3, pp. 96-96
Open Access | Times Cited: 8
Lower ileostomy output among patients with postoperative colorectal cancer after being supplemented with partially hydrolyzed guar gum: Outcome of a pilot study
Chiou Yi Ho, Hazreen Abdul Majid, Norshariza Jamhuri, et al.
Nutrition (2022) Vol. 103-104, pp. 111758-111758
Open Access | Times Cited: 7
Deducing the Interplay Between Gut Flora and Respiratory Diseases: A New Therapeutic Strategy?
Ardra Thottarath Prasanthan, Aswin Damodaran, Nirdesh Salim Kumar, et al.
Indian Journal of Microbiology (2022) Vol. 63, Iss. 1, pp. 1-17
Open Access | Times Cited: 7
Importance of gut microbiome regulation for the prevention and recovery process after SARS‑CoV‑2 respiratory viral infection (Review)
Nuroh Najmi, Imam Megantara, Lovita Andriani, et al.
Biomedical Reports (2022) Vol. 16, Iss. 4
Open Access | Times Cited: 6
The contribution of food bioactives and nutrition to the management of COVID-19
Klaus W. Lange
Journal of Future Foods (2022) Vol. 2, Iss. 1, pp. 13-17
Open Access | Times Cited: 6
Research Progress in the Treatment of Complications and Sequelae of COVID-19
Jinpeng Wang, Kuoyun Zhu, Yuchuan Xue, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 8
Synbiotic for Prevention of SARS-Cov2 Infection in High Risk Hospital Staffs: A Randomized Controlled Trial
Hamid Ahanchian, Alireza Ranjbar, Hamidreza Reihani, et al.
Open Journal of Nursing (2021) Vol. 11, Iss. 05, pp. 281-290
Open Access | Times Cited: 7
Celiac Disease in Children: Draft Clinical Guidelines
Е.А. Roslavtseva, Yu. А. Dmitrieva, И. Н. Захарова, et al.
Experimental and Clinical Gastroenterology (2021), Iss. 4, pp. 199-227
Open Access | Times Cited: 6
Parallels Between NeuroHIV and NeuroCOVID-19: Considerations for a Post-COVID-19 Era
David E. Vance, Joseph Perazzo, Pariya L. Fazeli
Journal of the Association of Nurses in AIDS Care (2021) Vol. 32, Iss. 5, pp. e55-e59
Open Access | Times Cited: 6
Nutrition and COVID-19
John C. Mathers
British Journal Of Nutrition (2021) Vol. 127, Iss. 10, pp. 1441-1442
Open Access | Times Cited: 6
Frequently ill children: A new vision of the old problem
V. L. Gritsinskaya, В.П. Новикова
Meditsinskiy sovet = Medical Council (2024), Iss. 19, pp. 224-229
Open Access
Gut Microbiota Modulation for Therapeutic Management of Various Diseases: A New Perspective Using Stem Cell Therapy
Lamiaa A. Ahmed, Khaled F. Al-Massri
Current Molecular Pharmacology (2022) Vol. 16, Iss. 1, pp. 43-59
Closed Access | Times Cited: 3

Scroll to top